Literature DB >> 11549427

Willingness-to-pay for colorectal cancer screening.

E Frew1, J L Wolstenholme, D K Whynes.   

Abstract

Willingness-to-pay (WTP) techniques are increasingly being used in economic evaluation, as a means of assessing the value of new health care technologies. This paper presents the results of a WTP investigation of two types of screening for colorectal cancer. A questionnaire was issued to a general population via general practitioners (GPs), yielding a sample of approximately 2000 cases for analysis. Regression models demonstrated that WTP was significantly influenced by factors such as gender, income, age, risk perceptions, illness experiences and health beliefs. The median WTP for screening emerged as being pound30 or pound50, depending on the method used to elicit WTP, but independent of the screening protocol. Combining the results with those from related research, it emerged, first, that WTP subjects offered higher values for flexible sigmoidoscopy screening than the costs actually incurred by revealed preference studies and, second, they offered WTP values similar to the likely resource costs of the screening procedures.

Entities:  

Mesh:

Year:  2001        PMID: 11549427     DOI: 10.1016/s0959-8049(01)00200-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  23 in total

1.  Assessing willingness to pay for cancer prevention.

Authors:  Michael A Milligan; Alok K Bohara; José A Pagán
Journal:  Int J Health Care Finance Econ       Date:  2010-07-16

2.  A game-theoretic framework for estimating a health purchaser's willingness-to-pay for health and for expansion.

Authors:  Reza Yaesoubi; Stephen D Roberts
Journal:  Health Care Manag Sci       Date:  2010-08-12

3.  Measuring Preferences for Colorectal Cancer Screening: What are the Implications for Moving Forward?

Authors:  Deborah Marshall; S Elizabeth McGregor; Gillian Currie
Journal:  Patient       Date:  2010-06-01       Impact factor: 3.883

4.  Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats.

Authors:  David K Whynes; Emma J Frew; Jane L Wolstenholme
Journal:  Int J Health Care Finance Econ       Date:  2005-12

5.  Lessons from state mandates of preventive cancer screenings.

Authors:  Wendy Yi Xu; Bryan Dowd; Jean Abraham
Journal:  Eur J Health Econ       Date:  2015-03-15

Review 6.  Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments.

Authors:  S Wortley; G Wong; A Kieu; K Howard
Journal:  Patient       Date:  2014       Impact factor: 3.883

7.  Willingness to pay for colorectal cancer screening in Guangzhou.

Authors:  Qin Zhou; Yan Li; Hua-Zhang Liu; Ying-Ru Liang; Guo-Zhen Lin
Journal:  World J Gastroenterol       Date:  2018-11-07       Impact factor: 5.742

8.  Patient time requirements for anticoagulation therapy with warfarin.

Authors:  Daniel E Jonas; Betsy Bryant Shilliday; W Russell Laundon; Michael Pignone
Journal:  Med Decis Making       Date:  2009-09-22       Impact factor: 2.583

9.  Regulation and Consumer Interest in an Antioxidant-Enriched Ham Associated with Reduced Colorectal Cancer Risks.

Authors:  Stéphan Marette; Françoise Guéraud; Fabrice Pierre
Journal:  Nutrients       Date:  2021-05-03       Impact factor: 5.717

10.  Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy.

Authors:  Daniel E Jonas; Louise B Russell; Jon Chou; Michael Pignone
Journal:  Health Econ       Date:  2010-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.